Posted on 27 August 2010
Tags: Alcon, big pharma, Novartis
Novartis AG and Nestlé S.A. have announced that they have completed the purchase and sale of approximately 156 million shares of Alcon, Inc. for US$28.3 billion in cash. Read the full details of this $28.3bn deal here
Click here to cancel reply.
Email (will not be published) (required)
Your website (optional)
© 2019 Wildwood Ventures Ltd.